FREDERICK, MD--(Marketwired - Nov 1, 2016) - BioElectronics Corporation (OTC PINK: BIEL), the maker of advanced consumer pain
management medical devices, today announced that it has appointed PharmEvo https://www.pharmevo.biz as its ActiPatch® Musculoskeletal Pain Therapy distributor for Vietnam,
Kenya, Cambodia, Myanmar, Kenya and Sri Lanka.
PharmEvo was established in 1999, has a sales team of 850 people, and annual sales of over $300 million. Corporate
headquarters are in Karachi, Pakistan with 9 locations in Pakistan and international market coverage in Vietnam, Cambodia, Kenya,
Philippines, Myanmar, Sri Lanka, Guatemala, Kenya, Tanzania, Pakistan, Kazakhstan, and Uzbekistan. PharmEvo engaged in the
creation, development, manufacture and marketing of pharmaceutical products, including over-the-counter (OTC) medicines, medical
equipment and infant formulas. PharmEvo partners with the following international groups for bringing best quality products to
its consumers: Bioton (Poland), Lactalis (France), Omron (Japan), Becton Dickson (USA), etc.
Nadeem Rehmat, Director of PharmaEvo Business Development has expressed his confidence that ActiPatch Musculoskeletal
drug-free inexpensive pain therapy is a great fit to their OTC line.
"We are pleased to have PharmEvo selling our ActiPatch products in Southeast Asia. We believe our unique cost effective
drug-free pain therapy will have excellent market acceptance in Asia," said Erin Sanders, BioElectronics Sales Manager.
About BioElectronics Corporation
BioElectronics Corporation is a leader in biophysics and the maker of an industry leading family of
disposable, drug-free, pain therapy devices: ActiPatch® Therapy, over-the-counter treatment for back pain and other
musculoskeletal complaints; RecoveryRx® Devices for chronic wounds and post-operative wound care; Allay® Menstrual Pain Therapy;
and HealFast® Therapy for dogs, cats and horses. For more information, please visit www.bielcorp.com.